Cargando…
COVID-19 Antibody Tests: A Valuable Public Health Tool with Limited Relevance to Individuals
Antibody tests for detecting past infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have many uses for public health decision making, but demand has largely come from individual consumers. This review focuses on the individual relevance of antibody tests: their accuracy in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836413/ https://www.ncbi.nlm.nih.gov/pubmed/33234439 http://dx.doi.org/10.1016/j.tim.2020.11.002 |
_version_ | 1783642744220024832 |
---|---|
author | West, Rachel Kobokovich, Amanda Connell, Nancy Gronvall, Gigi Kwik |
author_facet | West, Rachel Kobokovich, Amanda Connell, Nancy Gronvall, Gigi Kwik |
author_sort | West, Rachel |
collection | PubMed |
description | Antibody tests for detecting past infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have many uses for public health decision making, but demand has largely come from individual consumers. This review focuses on the individual relevance of antibody tests: their accuracy in detecting prior infection, what past SARS-CoV-2 infection can currently infer about future immunity or possible medical sequelae, and the potential future importance of antibody tests for vaccine selection and medical screening. Given uncertainty about the antibody tests (quality, accuracy level, positive predictive value) and what those tests might indicate immunologically (durability of antibodies and necessity for protection from reinfection), seropositive test results should not be used to inform individual decision making, and antibody testing should remain a tool of public health at this time. |
format | Online Article Text |
id | pubmed-7836413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78364132021-01-26 COVID-19 Antibody Tests: A Valuable Public Health Tool with Limited Relevance to Individuals West, Rachel Kobokovich, Amanda Connell, Nancy Gronvall, Gigi Kwik Trends Microbiol Review Antibody tests for detecting past infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have many uses for public health decision making, but demand has largely come from individual consumers. This review focuses on the individual relevance of antibody tests: their accuracy in detecting prior infection, what past SARS-CoV-2 infection can currently infer about future immunity or possible medical sequelae, and the potential future importance of antibody tests for vaccine selection and medical screening. Given uncertainty about the antibody tests (quality, accuracy level, positive predictive value) and what those tests might indicate immunologically (durability of antibodies and necessity for protection from reinfection), seropositive test results should not be used to inform individual decision making, and antibody testing should remain a tool of public health at this time. The Authors. Published by Elsevier Ltd. 2021-03 2020-11-06 /pmc/articles/PMC7836413/ /pubmed/33234439 http://dx.doi.org/10.1016/j.tim.2020.11.002 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review West, Rachel Kobokovich, Amanda Connell, Nancy Gronvall, Gigi Kwik COVID-19 Antibody Tests: A Valuable Public Health Tool with Limited Relevance to Individuals |
title | COVID-19 Antibody Tests: A Valuable Public Health Tool with Limited Relevance to Individuals |
title_full | COVID-19 Antibody Tests: A Valuable Public Health Tool with Limited Relevance to Individuals |
title_fullStr | COVID-19 Antibody Tests: A Valuable Public Health Tool with Limited Relevance to Individuals |
title_full_unstemmed | COVID-19 Antibody Tests: A Valuable Public Health Tool with Limited Relevance to Individuals |
title_short | COVID-19 Antibody Tests: A Valuable Public Health Tool with Limited Relevance to Individuals |
title_sort | covid-19 antibody tests: a valuable public health tool with limited relevance to individuals |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836413/ https://www.ncbi.nlm.nih.gov/pubmed/33234439 http://dx.doi.org/10.1016/j.tim.2020.11.002 |
work_keys_str_mv | AT westrachel covid19antibodytestsavaluablepublichealthtoolwithlimitedrelevancetoindividuals AT kobokovichamanda covid19antibodytestsavaluablepublichealthtoolwithlimitedrelevancetoindividuals AT connellnancy covid19antibodytestsavaluablepublichealthtoolwithlimitedrelevancetoindividuals AT gronvallgigikwik covid19antibodytestsavaluablepublichealthtoolwithlimitedrelevancetoindividuals |